Rules to regulate e-pharmacies need some more time: Centre to Delhi HC

The Ministry of Health and Family Welfare draft rules were challenged in the plea to further amend the Drugs and Cosmetics Rules

Pharma sector, Pharmacy, Pharma regulation
Illustration: Binay Sinha
IANS New Delhi
2 min read Last Updated : Mar 15 2023 | 9:36 PM IST

The Central government on Wednesday told the Delhi High Court that a proposal for framing rules to regulate e-pharmacies was under consideration and some more time was needed.

The Centre's response came after a division bench of Chief Justice Satish Chandra Sharma and Justice Subramonium Prasad asked it to file a status report on petitions seeking a ban on illegal sale of drugs online.

"A proposal for framing rules to regulate e-pharmacies was under consideration and some more time was needed," the Centre's counsel told the court.

However, the petitioner's lawyer contended that the rules are being framed for the last 5-6 years but nothing concrete has been done yet.

The court listed the matter for the next hearing on May 22.

The Ministry of Health and Family Welfare draft rules were challenged in the plea to further amend the Drugs and Cosmetics Rules.

The Ministry's August 2018 notification was challenged by the South Chemists and Distributors Association in a petition saying that ignoring the health hazards caused due to online sale of medicines without proper regulations, the draft rules are being pushed through in serious violation of the law.

The petition has sought contempt action against the e-pharmacies for continuing to sell drugs online despite a high court order staying such activity and contempt action against the Central government for allegedly not taking any step against the defaulting e-pharmacies.

On December 12, 2018, the Delhi High Court had stayed the online sale of drugs without licence by pharmacies while hearing petitioner Zaheer Ahmed's PIL.

--IANS

spr/vd

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CentreDelhi High Courtpharmacy

First Published: Mar 15 2023 | 9:36 PM IST

Next Story